Unlocking precision medicine through expert NGS panel design
Tuesday, February 13, 2024
4:00 PM CEST
By Dr. Marcel Trautmann, Koenraad Eycken, Dr. James Flynn
Join our webinar to discover revolutionary insights into personalised cancer treatment with OncoDEEP, learn more about advanced genomic signature identification, and see how leading German healthcare providers are implementing these innovations in clinical settings. Don’t miss this opportunity to transform your approach to cancer research and treatment!
!Please note that places are limited!
5 reasons to attend this webinar
- A comprehensive overview of personalised cancer treatments: Gain valuable insights into how OncoDEEP can transform your approach to personalised cancer therapy.
- Expert panel design for complex genomic signatures: Discover the methods used to identify complex genomic signatures such as HRD, TMB, MSI and LOH. Learn how these techniques are helping to advance cancer research and treatment.
- Innovative technology in cancer research: Understand why Twist hybrid capture technology stands out in the field and how it improves test efficiency.
- Validation and adoption in the real world: Learn about the practical application and validation of the test, and how it has been successfully adopted by one of Germany's largest healthcare providers. This real-world example will illustrate the impact and effectiveness of the test.
- Maximising the value of NGS data in clinical settings: Explore strategies for fully exploiting your next-generation sequencing (NGS) data in clinical settings to improve both research and patient care.
Our speakers
Marcel Trautmann
Assistant Professor & Head Molecular Diagnostics and Research — Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster
Koenraad Eycken
Chief Product Officer, OncoDNA
Dr. James Flynn
Staff Product Manager, Twist Bioscience
